Metastatic Colon Cancer, Version 3.2013

• DOI: 10.6004/jnccn.2013.0022
• Publication Date: 2017-04-14T12:02:36Z
• Authors: Al B. Benson; Tanios Bekaii-Saab; Emily Chan; Yi-Jen Chen; Michael A. Choti; Harry S. Cooper; Paul F. Engstrom; Peter C. Enzinger; Marwan G. Fakih; Moon J. Fenton; Charles S. Fuchs; Jean L. Grem; Steven Hunt; Ahmed Kamel; Lucille A. Leong; Edward Lin; Kilian Salerno May; Mary F. Mulcahy; Kate Murphy; Eric Rohren; David P. Ryan; Leonard Saltz; Sunil Sharma; David Shibata; John M. Skibber; William Small; Constantinos T. S...; Alan P. Venook; Christopher G. Wi...; Kristina M. Gregory; Deborah A. Freedm...
• Keywords: 03 medical and health sciences; 0302 clinical medicine; Colonic Neoplasms; Practice Guidelines as Topic; Humans; Neoplasm Metastasis; Medical Oncology; 3. Good health

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Colon Cancer begin with the clinical presentation of the patient to the primary care physician or gastroenterologist and address diagnosis, pathologic staging, surgical management, perioperative treatment, patient surveillance, management of recurrent and metastatic disease, and survivorship. The NCCN Colon Cancer Panel meets annually to review comments from reviewers within their institutions and to reevaluate and update their recommendations. In addition, the panel has interim conferences as new data necessitate. These NCCN Guidelines Insights summarize the NCCN Colon Cancer Panel's discussions surrounding metastatic colorectal cancer for the 2013 update of the guidelines. Importantly, changes were made to the continuum of care for patients with advanced or metastatic disease, including new drugs and an additional line of therapy.